home / stock / ampe / ampe news


AMPE News and Press, Ampio Pharmaceuticals Inc. From 09/15/21

Stock Information

Company Name: Ampio Pharmaceuticals Inc.
Stock Symbol: AMPE
Market: OTC
Website: ampiopharma.com

Menu

AMPE AMPE Quote AMPE Short AMPE News AMPE Articles AMPE Message Board
Get AMPE Alerts

News, Short Squeeze, Breakout and More Instantly...

AMPE - YY, NNVC and REKR among mid-day movers

Gainers: GreenSky (NASDAQ:GSKY) +53%. IronNet (NYSE:IRNT) +27%. Sphere (NASDAQ:ANY) +22%. Allied Healthcare Products (NASDAQ:AHPI) +19%. Actinium Pharmaceuticals ATNM +16%. Ampio Pharmaceuticals (NYSE:AMPE) +15%. Inozyme Pharma (NASDAQ:INZY) +15%. Seres Therapeutics (...

AMPE - Ampio Pharmaceuticals, 180 Life Sciences leads healthcare gainers; Nuwellis, Berkeley Lights among major losers

Gainers: Ampio Pharmaceuticals (NYSE:AMPE) +22%, 180 Life Sciences (NASDAQ:ATNF) +17%, Brainstorm Cell Therapeutics (NASDAQ:BCLI) +15%, Instil Bio (NASDAQ:TIL) +16%, G Medical Innovations (NASDAQ:GMVD) +15%. Losers: Nuwellis (NASDAQ:NUWE) -26%...

AMPE - Penny Stocks For Your Biotech Watch List In September 2021

Penny Stocks For You List This Month Penny stocks are picking up steam this month. Thanks to a constant search for volatility, these cheap stocks are the shining light amid a sea of red in the broader markets. Some may use ETFs like the Russell Small-Cap ETF ( NYSE:IWM ) to gauge re...

AMPE - Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK)

Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK) - Ampion™ demonstrated statistically significant reduction in pain and improvement in function at 12 weeks in se...

AMPE - Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action

Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action Research shows Ampion may be used to treat conditions that are supported for dexamethasone but with fewer or less harmful side effects PR Newswire ENGLEWOOD, Colo....

AMPE - Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting

Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting PR Newswire ENGLEWOOD, Colo. , Aug. 12, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancem...

AMPE - Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences PR Newswire ENGLEWOOD, Colo. , Aug. 11, 2021 /PRNewswire/ -- Ampio Pharmaceuticals , Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of im...

AMPE - Why Penny Stocks Investors Are Bullish on These 3 Small-Caps

3 Penny Stocks That Are Seeing Bullish Interest Right Now Today, penny stocks and blue chips both rose in value alongside the Dow pushing up by over 300 points. One of the major catalysts for this is the Labor Dept. in the U.S. stating that first-time jobless claims dropped to 385,000. ...

AMPE - Here's Why Ampio Pharmaceuticals Stock Is Surging Today

Shares of Ampio Pharmaceuticals (NYSEMKT: AMPE) are on the rise after the company released a positive second-quarter earnings report this morning. News of progress with the company's experimental COVID-19 treatment, Ampion, pushed the stock 17.5% higher as of 1:06 p.m. on Thursday. ...

AMPE - Ampio Pharmaceuticals, Inc. (AMPE) CEO Mike Macaluso on Q2 2021 Results - Earnings Call Transcript

Ampio Pharmaceuticals, Inc. (AMPE) Q2 2021 Earnings Conference Call August 4, 2021 04:30 PM ET Company Participants Dan Stokely - Chief Financial Officer Mike Macaluso - Chairman & Chief Executive Officer Holli Cherevka - Chief Operating Officer David Bar-Or - Director & Founder Confe...

Previous 10 Next 10